Strykr Analysis
NeutralStrykr Pulse 55/100. Rotation is real, but risks of a mega-cap rebound are non-trivial. Threat Level 3/5.
The S&P 500’s mega-cap darlings, once the market’s unassailable engine, are now the drag on performance, and the rotation is not just a blip. For traders who built their books around the Mag 7’s relentless bid, June has been a lesson in humility and risk management. The index, weighted down by its largest constituents, is underperforming even as small and microcaps quietly outperform. The narrative of ‘AI will save us all’ is colliding with valuation gravity, and the result is a market that’s finally rewarding ‘the rest’ after years of neglect.
Let’s get specific. According to Seeking Alpha’s June 28 report, mega-cap stocks have lagged all month, and their sheer weight in the S&P 500 means the entire index is feeling the pain. The Mag 7, which commands roughly 34% of the S&P 500 and a staggering 38% of the Nasdaq 100, has gone from market propellant to performance anchor. Meanwhile, small and microcaps are putting in the kind of relative performance that would have been unthinkable in 2023. Healthcare and REITs are attracting fresh capital, and the sector rotation is visible in daily flows and ETF positioning. The S&P 500’s breadth has improved, but not in the way most bulls would have hoped. Instead of a rising tide, we’re getting a slow-motion transfer of momentum from the top to the bottom of the market cap ladder.
The context is everything. For the past five years, the S&P 500 has been a story of concentration risk. The Mag 7, Apple, Microsoft, Alphabet, Amazon, Meta, Nvidia, and Tesla, have done the heavy lifting, masking weakness everywhere else. But as AI enthusiasm meets the reality of slowing earnings growth and stretched multiples, the market is finally recalibrating. The technicals are ugly. The S&P 500’s advance-decline line has diverged from price for weeks. Relative strength in the equal-weight index is at a two-year high. The last time we saw this kind of rotation was in 2016, when the Trump reflation trade briefly lifted all boats. This time, it’s not fiscal stimulus or tax cuts driving the shift. It’s valuation fatigue and the realization that mega-cap multiples can’t expand forever.
The analysis is brutal for anyone still overweight the big names. The Mag 7’s collective market cap has dropped 7% in June, erasing over $800 billion in paper gains. Meanwhile, the S&P 600 Small Cap Index is up 4.2% month-to-date, and microcaps have outperformed large caps by 310 basis points. ETF flows confirm the trend: investors are rotating out of tech-heavy funds and into value, healthcare, and real estate. The AI narrative is still alive, but it’s no longer enough to justify nosebleed valuations. Abby Joseph Cohen, speaking on Bloomberg Money, warned that lofty stock prices may be hiding risks that only become apparent when breadth improves. In other words, the market is finally waking up to the dangers of concentration risk, and the unwind is just beginning.
Strykr Watch
Technically, the S&P 500 is flirting with key support at 5,400, with resistance at 5,550. The equal-weight S&P 500 ETF (RSP) is outperforming the cap-weighted index, and the spread is widening. RSI on the Mag 7 basket is below 40, signaling persistent weakness. Healthcare and REITs are breaking out of multi-month bases, with XLV and VNQ both posting new 52-week highs. Watch for a decisive break below 5,400 on the S&P 500, which could trigger a cascade of risk-off flows. Conversely, a bounce from this level could see a short-term reversal, but the structural rotation is unlikely to reverse overnight. For sector traders, the setup favors long value, healthcare, and REITs, with tight stops below recent breakout levels.
The risks are clear. If mega-caps stage a violent short-covering rally, the rotation trade could get steamrolled. A dovish Fed surprise or a sudden improvement in AI-driven earnings could reignite the big-cap bid. There’s also the risk that small and microcaps are simply enjoying a dead-cat bounce, with no fundamental improvement to back up the price action. If credit spreads widen or macro data deteriorates, the risk-on rotation could reverse as quickly as it started. For now, though, the weight of evidence favors staying nimble and respecting the new regime.
On the opportunity side, traders can play the rotation by overweighting equal-weight S&P 500, healthcare, and REITs, while underweighting the Mag 7. Pair trades, long value, short tech, are back in vogue. There’s also room for tactical long positions in small and microcaps, especially those with improving earnings revisions and insider buying. For the bold, shorting mega-cap rallies into resistance could be the trade of the summer, with stops above recent highs. The days of buying every tech dip are over, at least for now.
Strykr Take
The S&P 500’s mega-cap era isn’t dead, but it’s on life support. The rotation to ‘the rest’ is real, and traders who ignore it are playing last year’s game. Adapt or get left behind.
datePublished: 2026-06-28 04:45 UTC
Sources (5)
A Month For 'The Rest'
We've made numerous mentions of the weakness in mega-cap stocks so far this month, and given their weightings in the S&P 500, the impact on the index
Chip Makers Are Profiting Off AI at the Expense of Just About Everyone Else
We are witnessing an extraordinary transfer of cash from the providers of AI—and, perhaps one day, AI users—to memory-chip makers.
Here is how Alan Greenspan ran the Fed—and how Kevin Warsh's approach compares
The approach of the new Federal Reserve head might not always align with the standard his predecessor set.
Tanker struck in Strait of Hormuz as U.S.-Iran tensions escalate
A tanker in the Strait of Hormuz was reported struck by a projectile on Saturday, the latest escalation of tensions between the U.S. and Iran. The U.
Stock Valuations Should Worry Investors: Abby Joseph Cohen
Abby Joseph Cohen, professor at Columbia Business School, joins Lisa Mateo and Tom Keene on "Bloomberg Money." Lofty stock prices may be hiding risks